191 related articles for article (PubMed ID: 31900718)
1. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
Zhao XM; Zhang J; Liang YN; Niu YC
Dig Dis Sci; 2020 Oct; 65(10):2925-2936. PubMed ID: 31900718
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activation in vitro.
Dong H; Guo H; Liang Y; Wang X; Niu Y
Free Radic Res; 2017 Feb; 51(2):167-178. PubMed ID: 28147890
[TBL] [Abstract][Full Text] [Related]
3. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
4. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV and ferulic acid synergistically promote neurite outgrowth through Nrf2 activation.
Liang Y; Zou Y; Niu C; Niu Y
Mech Ageing Dev; 2019 Jun; 180():70-81. PubMed ID: 30978363
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells.
Liu H; Wei W; Sun WY; Li X
J Ethnopharmacol; 2009 Apr; 122(3):502-8. PubMed ID: 19429320
[TBL] [Abstract][Full Text] [Related]
7. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway.
Li X; Wang X; Han C; Wang X; Xing G; Zhou L; Li G; Niu Y
Free Radic Biol Med; 2013 Jul; 60():168-76. PubMed ID: 23459070
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy.
Meng LQ; Tang JW; Wang Y; Zhao JR; Shang MY; Zhang M; Liu SY; Qu L; Cai SQ; Li XM
Br J Pharmacol; 2011 Apr; 162(8):1805-18. PubMed ID: 21232035
[TBL] [Abstract][Full Text] [Related]
10. Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.
Du N; Xu Z; Gao M; Liu P; Sun B; Cao X
Drug Des Devel Ther; 2018; 12():3517-3524. PubMed ID: 30425453
[TBL] [Abstract][Full Text] [Related]
11. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
Gong Y; Yang Y
Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
[TBL] [Abstract][Full Text] [Related]
12. Effect of ursodeoxycholic acid on TGF beta1/Smad signaling pathway in rat hepatic stellate cells.
Liang TJ; Yuan JH; Tan YR; Ren WH; Han GQ; Zhang J; Wang LC; Qin CY
Chin Med J (Engl); 2009 May; 122(10):1209-13. PubMed ID: 19493473
[TBL] [Abstract][Full Text] [Related]
13. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1).
Abd El Motteleb DM; Ibrahim IAAE; Elshazly SM
Toxicol Appl Pharmacol; 2017 Nov; 335():64-71. PubMed ID: 28974454
[TBL] [Abstract][Full Text] [Related]
15. Coffee consumption prevents fibrosis in a rat model that mimics secondary biliary cirrhosis in humans.
Arauz J; Zarco N; Hernández-Aquino E; Galicia-Moreno M; Favari L; Segovia J; Muriel P
Nutr Res; 2017 Apr; 40():65-74. PubMed ID: 28473062
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
Zhang C; Li L; Hou S; Shi Z; Xu W; Wang Q; He Y; Gong Y; Fang Z; Yang Y
J Ethnopharmacol; 2021 Oct; 279():114350. PubMed ID: 34157326
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
18. Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway.
Du JX; Sun MY; Du GL; Li FH; Liu C; Mu YP; Chen GF; Long AH; Bian YQ; Liu J; Liu CH; Hu YY; Xu LM; Liu P
BMC Complement Altern Med; 2012 Apr; 12():33. PubMed ID: 22471627
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression.
Su Y; Chen Q; Ma K; Ju Y; Ji T; Wang Z; Li W; Li W
Pharmacol Rep; 2019 Apr; 71(2):319-329. PubMed ID: 30826573
[TBL] [Abstract][Full Text] [Related]
20. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]